PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Cost of Revenue in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Pacific Biosciences Of California, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2011 to Q3 2024.
  • Pacific Biosciences Of California, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $30M, a 20.7% decline year-over-year.
  • Pacific Biosciences Of California, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $136M, a 12.5% increase year-over-year.
  • Pacific Biosciences Of California, Inc. annual Cost of Revenue for 2023 was $148M, a 86.4% increase from 2022.
  • Pacific Biosciences Of California, Inc. annual Cost of Revenue for 2022 was $79.3M, a 10.6% increase from 2021.
  • Pacific Biosciences Of California, Inc. annual Cost of Revenue for 2021 was $71.7M, a 54.7% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $136M $30M -$7.83M -20.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $144M $30.1M -$1.95M -6.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $146M $27.5M -$1.61M -5.53% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $148M $48.8M +$26.6M +120% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $121M $37.8M +$19M +101% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $102M $32M +$12.8M +66.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $89.4M $29.1M +$10.1M +53.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $79.3M $22.2M +$2.96M +15.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $76.3M $18.8M -$759K -3.89% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $77.1M $19.3M +$2.42M +14.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $74.7M $19M +$3M +18.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $71.7M $19.3M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $19.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $16.9M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $16M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q1 2018 $54.9M $12.1M -$3.91M -24.5% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-02
Q4 2017 $58.8M $15.4M +$1.09M +7.62% Oct 1, 2017 Dec 31, 2017 10-K 2018-02-26
Q3 2017 $57.7M $15.3M +$2.84M +22.7% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-02
Q2 2017 $54.9M $12.1M +$1.97M +19.5% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-02
Q1 2017 $52.9M $16M +$6.36M +66% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $46.6M $14.3M +$4.53M +46.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-26
Q3 2016 $42M $12.5M +$5.11M +69.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $36.9M $10.1M -$330K -3.16% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $37.2M $9.62M -$2.1M -17.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $39.3M $9.82M -$2.65M -21.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 $42M $7.37M -$95K -1.27% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $42.1M $10.4M +$2.13M +25.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $39.9M $11.7M +$2.75M +30.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $37.2M $12.5M +$6.52M +110% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-06
Q3 2014 $30.7M $7.46M +$1.28M +20.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $29.4M $8.3M +$3.31M +66.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $26.1M $8.97M +$4.32M +92.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $21.8M $5.95M +$694K +13.2% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 $21.1M $6.18M +$3.59M +139% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $17.5M $4.99M -$2.03M -28.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $19.5M $4.65M -$5.54M -54.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $25M $5.25M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 $2.59M -$4.61M -64% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $7.02M +$4.29M +157% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $10.2M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q3 2011 $7.19M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 $2.73M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.